Jesper Jurlander

Rigshospitalet — Denmark

Medicine · Health Sciences

33h-index3.8kcitations79works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(56), Lymphoma Diagnosis and Treatment(44), Immunodeficiency and Autoimmune Disorders(21), Acute Lymphoblastic Leukemia research(11), Monoclonal and Polyclonal Antibodies Research(8)

Publications79 total

Hematological Malignancies, Leukemias, and Lymphomas
2017
Hematological Malignancies, Leukemias, and Lymphomas
2015
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
Blood·2014· 52 cited
Combination of two anti‐<scp>CD</scp>5 monoclonal antibodies synergistically induces complement‐dependent cytotoxicity of chronic lymphocytic leukaemia cells
British Journal of Haematology·2013· 30 citedOpen Access
Molecular characterization of neoplastic and normal “sister” lymphoblastoid B-cell lines from chronic lymphocytic leukemia
Leukemia & lymphoma/Leukemia and lymphoma·2013· 18 citedOpen Access
Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis
Leukemia & lymphoma/Leukemia and lymphoma·2012· 2 cited
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
Blood·2012· 382 citedOpen Access
Immunochemotherapy with Low-Dose Subcutaneous Alemtuzumab (A) Plus Oral Fludarabine and Cyclophosphamide (FC) Is Safe and Induces More and Deeper Complete Remissions in Untreated Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) Than Chemotherapy with FC Alone. An Early Analysis of the Randomized Phase-III HOVON68 CLL Trial
Blood·2011· 13 cited
Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity
Leukemia·2011· 73 citedOpen Access
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
Haematologica·2011· 100 citedOpen Access
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
Haematologica·2011· 57 citedOpen Access
Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily
Leukemia & lymphoma/Leukemia and lymphoma·2011· 17 cited
Hematological Malignancies, Leukemias and Lymphomas
2011· 8 cited
The Composition of the B Cell Receptor Repertoire In 7428 Cases of Chronic Lymphocytic Leukemia: One Third Stereotyped, Two Thirds Heterogeneous - What Does This Mean?
Blood·2010· 4 cited
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
Leukemia Research·2010· 38 citedOpen Access
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
Haematologica·2010· 36 citedOpen Access
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
British Journal of Haematology·2010· 38 citedOpen Access
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
Haematologica·2010· 53 citedOpen Access
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in chronic lymphocytic leukemia
2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
Nature Genetics·2010· 224 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Richard Rosenquist(16), Anne Mette Buhl(12), Christian H. Geisler(11), Lone Bredo Pedersen(10), Gunnar Juliusson(10), Karin E. Smedby(9), Nicola Cahill(8), Mahmoud Mansouri(8), Christian H. Geisler(7), Rebeqa Gunnarsson(7), Κώστας Σταματόπουλος(6), Mattias Jansson(6), Fiona Murray(5), Frédéric Davi(5), Pär Josefsson(5), Henrik Hjalgrim(5), Anders Isaksson(5), Henrik Leffers(5), Peter de Nully Brown(5), Nikos Darzentas(4)